Cargando…
Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway
The use of mesenchymal stem cells (MSCs) has become a new strategy for treating diabetic kidney disease (DKD). However, the role of placenta derived mesenchymal stem cells (P-MSCs) in DKD remains unclear. This study aims to investigate the therapeutic application and molecular mechanism of P-MSCs on...
Autores principales: | Han, Xiudan, Wang, Jiao, Li, Ruilin, Huang, Meiling, Yue, Guanru, Guan, Lulu, Deng, Yuanyuan, Cai, Wei, Xu, Jixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003373/ https://www.ncbi.nlm.nih.gov/pubmed/36902127 http://dx.doi.org/10.3390/ijms24054696 |
Ejemplares similares
-
PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2011) -
Astrocytes Protect Neurons from Aβ(1-42) Peptide-Induced Neurotoxicity Increasing TFAM and PGC-1 and Decreasing PPAR-γ and SIRT-1
por: Aguirre-Rueda, Diana, et al.
Publicado: (2015) -
Maternal obesity inhibits placental angiogenesis by down-regulating the SIRT1/PGC-1α pathway
por: Peng, Huilin, et al.
Publicado: (2022) -
Expression of Mitochondrial Regulators PGC1α and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian Carcinoma
por: Gabrielson, Marike, et al.
Publicado: (2014) -
Testosterone Deficiency Caused by Castration Modulates Mitochondrial Biogenesis Through the AR/PGC1α/TFAM Pathway
por: Liu, Can, et al.
Publicado: (2019)